SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-138119
Filing Date
2021-11-12
Accepted
2021-11-12 16:31:01
Documents
61
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q rzlt-20210930x10q.htm   iXBRL 10-Q 840675
2 EXHIBIT 31.1 rzlt-20210930xex31d1.htm EX-31.1 12671
3 EXHIBIT 32.1 rzlt-20210930xex32d1.htm EX-32.1 7216
  Complete submission text file 0001104659-21-138119.txt   4348554

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA rzlt-20210930.xsd EX-101.SCH 45752
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rzlt-20210930_cal.xml EX-101.CAL 33998
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rzlt-20210930_def.xml EX-101.DEF 159445
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE rzlt-20210930_lab.xml EX-101.LAB 318716
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rzlt-20210930_pre.xml EX-101.PRE 278362
9 EXTRACTED XBRL INSTANCE DOCUMENT rzlt-20210930x10q_htm.xml XML 564273
Mailing Address 201 REDWOOD SHORES PARKWAY, SUITE 315 REDWOOD CITY CA 94065
Business Address 201 REDWOOD SHORES PARKWAY, SUITE 315 REDWOOD CITY CA 94065 650-847-1919
Rezolute, Inc. (Filer) CIK: 0001509261 (see all company filings)

IRS No.: 273440894 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39683 | Film No.: 211404075
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences